Related Experiment Video
Updated: May 28, 2026
06:41
A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
Published on: March 9, 2015
Uncovering Novel Landscape and Functional MicroRNA-Targets for Androgenetic Alopecia
Jian Chen1, Cheng Zheng1, Shizhao Liu1
1Department of Plastic and Aesthetic Surgery, Nanfang Hospital of Southern Medical University, Guangzhou, China.
Summary
This study explores microRNAs (miRNAs) in androgenetic alopecia (AGA), revealing potential molecular targets. MiR-146b-5p shows promise for promoting hair growth and reducing inflammation in AGA.
Area of Science:
- Molecular Biology
- Dermatology
- Genetics
Background:
- Androgenetic alopecia (AGA) is an inherited, androgen-driven hair loss condition.
- The role of microRNAs (miRNAs) in AGA pathophysiology is not fully understood.
- miRNAs are crucial for hair follicle (HF) development.
Purpose of the Study:
- To construct miRNA-mRNA regulatory networks in AGA.
- To investigate the role of miRNAs in AGA pathophysiology at the molecular level.
- To identify potential miRNA-based therapeutic targets for AGA.
Main Methods:
- Integrated miRNA and mRNA sequencing data to build regulatory networks.
- Established an organ-cultured balding AGA hair follicle model.
- Performed molecular validation of identified miRNAs and their targets.
Main Results:
- Downregulated predicted target genes in AGA HFs were linked to microenvironment remodeling and hair follicle stem cell (HFSC) dysfunction.
- Identified miRNAs potentially regulating key pathological processes in AGA, including androgen signaling, hair cycle, and inflammation.
- miR-146b-5p demonstrated potential to promote hair growth and ameliorate the inflammatory microenvironment in AGA HFs.
Conclusions:
- miRNA dysregulation plays a significant role in AGA.
- miR-146b-5p is a promising therapeutic target for androgenetic alopecia.
- Targeting miRNAs could offer novel treatment strategies for AGA by modulating key pathological pathways.
Related Concept Videos
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...